Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Cindy O'Bryant

Concepts (316)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
22
2025
2192
1.820
 Why?
Neoplasms
32
2025
2870
1.580
 Why?
Antiemetics
2
2024
49
0.810
 Why?
Piperidines
3
2021
217
0.770
 Why?
Pyridines
5
2015
605
0.760
 Why?
Pharmacists
5
2025
240
0.710
 Why?
Indazoles
1
2021
80
0.670
 Why?
Anilides
2
2013
84
0.660
 Why?
Liver
3
2021
1884
0.640
 Why?
Cancer Care Facilities
1
2020
48
0.600
 Why?
Immunoconjugates
2
2023
132
0.600
 Why?
Morpholines
1
2020
128
0.590
 Why?
Cisplatin
5
2024
334
0.590
 Why?
Drug Hypersensitivity
1
2020
90
0.560
 Why?
Drug Interactions
6
2024
397
0.530
 Why?
Protein Kinase Inhibitors
5
2024
968
0.500
 Why?
Histone Deacetylase Inhibitors
3
2019
220
0.480
 Why?
Receptor Protein-Tyrosine Kinases
2
2015
230
0.430
 Why?
Antineoplastic Combined Chemotherapy Protocols
11
2020
1953
0.400
 Why?
Carcinoma, Non-Small-Cell Lung
3
2026
1180
0.390
 Why?
Dose-Response Relationship, Drug
13
2021
2026
0.390
 Why?
Medical Oncology
3
2025
331
0.380
 Why?
Depsipeptides
1
2012
15
0.380
 Why?
Quinazolines
2
2011
266
0.370
 Why?
Lymphoma, T-Cell, Cutaneous
1
2012
45
0.370
 Why?
Area Under Curve
8
2021
329
0.340
 Why?
Pyrazoles
2
2013
509
0.340
 Why?
Antibodies, Monoclonal, Humanized
5
2026
985
0.340
 Why?
Sulindac
2
2008
16
0.340
 Why?
Neuroendocrine Tumors
1
2012
112
0.330
 Why?
Sirolimus
1
2012
281
0.330
 Why?
Nitriles
2
2008
205
0.320
 Why?
Neoplasm Proteins
2
2013
442
0.320
 Why?
Skin Neoplasms
2
2017
847
0.310
 Why?
Aged
31
2026
25850
0.300
 Why?
Middle Aged
34
2026
35762
0.300
 Why?
Lung Neoplasms
3
2026
2637
0.290
 Why?
Tosyl Compounds
1
2008
16
0.280
 Why?
Aromatase Inhibitors
1
2008
75
0.270
 Why?
Drug Dosage Calculations
1
2008
27
0.270
 Why?
Bone Density Conservation Agents
1
2008
81
0.270
 Why?
Liver Failure, Acute
1
2008
67
0.270
 Why?
Androgen Antagonists
1
2008
91
0.270
 Why?
Food
1
2008
149
0.250
 Why?
Pain
3
2011
777
0.250
 Why?
Fasting
1
2008
276
0.240
 Why?
Breast Neoplasms
3
2023
2447
0.240
 Why?
Humans
52
2026
144261
0.240
 Why?
Aged, 80 and over
10
2024
8243
0.230
 Why?
Osteoporosis
1
2008
236
0.230
 Why?
Liver Diseases
2
2019
304
0.230
 Why?
Professional Role
2
2017
158
0.230
 Why?
Acute Kidney Injury
3
2018
862
0.230
 Why?
Serotonin 5-HT3 Receptor Antagonists
1
2024
5
0.220
 Why?
Female
36
2026
77976
0.220
 Why?
Administration, Oral
5
2012
847
0.220
 Why?
Deoxycytidine
5
2011
221
0.220
 Why?
Platinum
1
2024
50
0.210
 Why?
Maximum Tolerated Dose
10
2020
212
0.210
 Why?
Male
35
2026
72035
0.210
 Why?
Hedgehog Proteins
2
2017
197
0.210
 Why?
Pancreatic Neoplasms
1
2012
918
0.210
 Why?
Antibodies, Monoclonal
4
2017
1519
0.210
 Why?
Adult
28
2025
40262
0.210
 Why?
Nausea
4
2020
111
0.210
 Why?
Midazolam
1
2024
72
0.200
 Why?
Cytochrome P-450 CYP3A
1
2024
93
0.200
 Why?
Angiogenesis Inhibitors
4
2010
236
0.200
 Why?
Vomiting
3
2020
130
0.180
 Why?
ErbB Receptors
2
2017
627
0.170
 Why?
Cohort Studies
5
2020
5935
0.170
 Why?
Sulfonamides
2
2019
580
0.170
 Why?
Prostatic Neoplasms
1
2008
974
0.170
 Why?
Apoptosis
3
2008
2430
0.170
 Why?
Lymphoma
2
2016
232
0.170
 Why?
Triple Negative Breast Neoplasms
1
2023
215
0.160
 Why?
Pyrimidines
2
2024
532
0.160
 Why?
Benzoxazoles
1
2020
20
0.160
 Why?
Trastuzumab
2
2023
118
0.160
 Why?
Fluorouracil
4
2011
235
0.160
 Why?
Drug Evaluation
1
2020
79
0.160
 Why?
Azepines
1
2020
107
0.150
 Why?
Health Knowledge, Attitudes, Practice
1
2008
1409
0.150
 Why?
Patient Care Team
1
2025
686
0.150
 Why?
Hydroxamic Acids
1
2019
94
0.150
 Why?
Analgesics, Opioid
1
2008
1131
0.150
 Why?
TWEAK Receptor
1
2017
6
0.130
 Why?
Pharmacogenomic Variants
1
2017
33
0.130
 Why?
Hematology
1
2017
21
0.130
 Why?
Vascular Endothelial Growth Factor A
4
2014
557
0.130
 Why?
Models, Biological
1
2024
1820
0.130
 Why?
Schools, Pharmacy
1
2017
47
0.130
 Why?
Pharmaceutical Services
1
2017
78
0.120
 Why?
Academic Medical Centers
1
2020
545
0.120
 Why?
Maytansine
1
2016
18
0.120
 Why?
Aminoglycosides
1
2016
26
0.120
 Why?
Specialty Boards
1
2016
42
0.120
 Why?
Mitogen-Activated Protein Kinases
1
2017
292
0.120
 Why?
Pain Management
2
2017
405
0.110
 Why?
Severity of Illness Index
3
2019
2917
0.110
 Why?
Drugs, Investigational
1
2015
31
0.110
 Why?
Carbazoles
1
2015
56
0.110
 Why?
Prescription Drugs
1
2016
110
0.110
 Why?
Phenylurea Compounds
1
2015
112
0.110
 Why?
Proto-Oncogene Proteins c-akt
1
2017
436
0.110
 Why?
Biomarkers, Tumor
4
2010
1313
0.110
 Why?
American Heart Association
1
2016
348
0.110
 Why?
Education, Pharmacy, Graduate
1
2014
12
0.110
 Why?
Insurance Claim Review
1
2014
82
0.100
 Why?
Drug Administration Schedule
5
2019
778
0.100
 Why?
Carboplatin
3
2009
160
0.100
 Why?
Specialization
1
2014
134
0.100
 Why?
Retrospective Studies
5
2026
17009
0.100
 Why?
Chronic Pain
1
2017
290
0.090
 Why?
Gonanes
1
2012
28
0.090
 Why?
Everolimus
1
2012
111
0.090
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2010
338
0.090
 Why?
Signal Transduction
2
2017
5221
0.090
 Why?
Biomarkers
3
2018
4254
0.090
 Why?
Erlotinib Hydrochloride
1
2011
72
0.090
 Why?
Clinical Trials as Topic
2
2015
1050
0.090
 Why?
Liver Function Tests
1
2011
106
0.090
 Why?
Phytotherapy
1
2011
74
0.090
 Why?
Enzyme Inhibitors
2
2012
824
0.080
 Why?
Delivery of Health Care, Integrated
1
2014
297
0.080
 Why?
Heart Ventricles
1
2015
756
0.080
 Why?
Glucuronidase
2
2008
25
0.080
 Why?
Antihypertensive Agents
1
2014
509
0.080
 Why?
Anti-Anxiety Agents
1
2010
45
0.080
 Why?
Curriculum
1
2017
1057
0.080
 Why?
Neoplasm Invasiveness
1
2011
508
0.080
 Why?
Oligosaccharides
2
2008
60
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
85
0.080
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2009
31
0.080
 Why?
Cell Proliferation
1
2017
2494
0.070
 Why?
Primary Health Care
2
2017
1710
0.070
 Why?
Drug Monitoring
1
2013
389
0.070
 Why?
Kidney
1
2017
1495
0.070
 Why?
Cannabinoids
1
2011
182
0.070
 Why?
Treatment Outcome
7
2015
11643
0.070
 Why?
TOR Serine-Threonine Kinases
1
2012
449
0.070
 Why?
Education, Pharmacy, Continuing
1
2008
2
0.070
 Why?
Capecitabine
4
2011
57
0.070
 Why?
Leukemia, Myeloid, Acute
1
2016
682
0.070
 Why?
Clinical Competence
1
2017
1241
0.070
 Why?
Equipment and Supplies
1
2008
35
0.070
 Why?
Androstadienes
1
2008
76
0.070
 Why?
Boronic Acids
1
2008
37
0.070
 Why?
Taxoids
2
2008
116
0.070
 Why?
Practice Guidelines as Topic
1
2016
1559
0.070
 Why?
Glycogen Synthase Kinase 3 beta
1
2008
72
0.070
 Why?
Community Pharmacy Services
1
2008
46
0.070
 Why?
Marijuana Smoking
1
2011
250
0.070
 Why?
Neovascularization, Pathologic
1
2010
286
0.070
 Why?
Farnesyltranstransferase
1
2007
21
0.070
 Why?
Bone Diseases, Metabolic
1
2008
56
0.070
 Why?
Etoposide
1
2008
166
0.070
 Why?
Glycogen Synthase Kinase 3
1
2008
81
0.070
 Why?
Drug Prescriptions
1
2010
280
0.070
 Why?
Reference Standards
1
2008
177
0.070
 Why?
Receptors, Vitronectin
1
2007
5
0.070
 Why?
Administration, Cutaneous
1
2008
125
0.070
 Why?
Integrin alphaVbeta3
1
2007
20
0.070
 Why?
Pyrazines
1
2008
92
0.070
 Why?
Snake Venoms
1
2007
20
0.070
 Why?
Absorptiometry, Photon
1
2008
275
0.070
 Why?
Oxycodone
1
2008
53
0.070
 Why?
Benzamides
1
2008
224
0.060
 Why?
Fatigue
4
2012
361
0.060
 Why?
Triazoles
1
2008
184
0.060
 Why?
Delayed-Action Preparations
1
2008
183
0.060
 Why?
Integrins
1
2007
89
0.060
 Why?
Pharmacogenetics
1
2008
172
0.060
 Why?
Anxiety Disorders
1
2010
368
0.060
 Why?
Alkyl and Aryl Transferases
1
2006
31
0.060
 Why?
Morphine
1
2008
168
0.060
 Why?
Matrix Metalloproteinase 9
1
2007
131
0.060
 Why?
Fentanyl
1
2008
126
0.060
 Why?
Animals
6
2020
38030
0.060
 Why?
Indoles
2
2008
501
0.060
 Why?
Metabolic Clearance Rate
2
2019
114
0.060
 Why?
Methadone
1
2008
110
0.060
 Why?
Thiophenes
1
2007
128
0.060
 Why?
Young Adult
3
2020
13990
0.060
 Why?
Cell Line, Tumor
3
2020
3539
0.060
 Why?
Chromatography, High Pressure Liquid
1
2008
593
0.060
 Why?
Societies, Pharmaceutical
2
2017
14
0.060
 Why?
Creatinine
2
2018
505
0.060
 Why?
Nigeria
1
2025
24
0.060
 Why?
Risk Factors
1
2020
10699
0.060
 Why?
Hypertension
1
2014
1254
0.060
 Why?
Granisetron
1
2024
6
0.060
 Why?
Palliative Care
2
2011
996
0.060
 Why?
Protein Binding
1
2011
2270
0.060
 Why?
Quinuclidines
1
2024
11
0.060
 Why?
Ondansetron
1
2024
19
0.060
 Why?
Isoquinolines
1
2024
44
0.050
 Why?
Tandem Mass Spectrometry
1
2008
576
0.050
 Why?
Xenograft Model Antitumor Assays
2
2020
928
0.050
 Why?
Occupational Exposure
1
2008
354
0.050
 Why?
Cannabis
1
2011
509
0.050
 Why?
Infusions, Intravenous
2
2019
423
0.050
 Why?
RNA, Catalytic
1
2005
189
0.050
 Why?
United States
5
2017
15876
0.050
 Why?
Glomerular Filtration Rate
2
2018
758
0.050
 Why?
Quinolones
1
2006
201
0.050
 Why?
Surveys and Questionnaires
2
2025
6021
0.050
 Why?
Prospective Studies
3
2024
7970
0.050
 Why?
Cardiovascular Diseases
1
2015
2134
0.050
 Why?
Drug Resistance, Neoplasm
2
2020
881
0.050
 Why?
Camptothecin
1
2023
140
0.050
 Why?
Pyrroles
1
2024
217
0.050
 Why?
Diarrhea
2
2015
192
0.050
 Why?
Heart Failure
1
2016
2314
0.050
 Why?
Adolescent
2
2020
22281
0.050
 Why?
Randomized Controlled Trials as Topic
1
2008
1705
0.040
 Why?
Neoplasm Staging
2
2019
1461
0.040
 Why?
Aurora Kinase A
1
2020
62
0.040
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
63
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
139
0.040
 Why?
Neutropenia
2
2009
155
0.030
 Why?
Organic Cation Transporter 2
1
2017
8
0.030
 Why?
Glutathione S-Transferase pi
1
2017
10
0.030
 Why?
Adenine
1
2020
339
0.030
 Why?
Partial Thromboplastin Time
2
2008
50
0.030
 Why?
Organic Cation Transport Proteins
1
2017
25
0.030
 Why?
Tissue Distribution
1
2018
327
0.030
 Why?
Amidine-Lyases
1
1997
1
0.030
 Why?
Anemia
2
2009
187
0.030
 Why?
HSP40 Heat-Shock Proteins
2
2007
26
0.030
 Why?
Fatty Acids, Monounsaturated
1
1997
54
0.030
 Why?
Mixed Function Oxygenases
1
1997
49
0.030
 Why?
Multienzyme Complexes
1
1997
67
0.030
 Why?
Cross-Sectional Studies
1
2008
5813
0.030
 Why?
Kidney Function Tests
1
2017
157
0.030
 Why?
Paclitaxel
2
2009
255
0.030
 Why?
Cation Transport Proteins
1
2017
118
0.030
 Why?
Regression Analysis
1
2018
998
0.030
 Why?
Cardiotoxins
1
2015
3
0.030
 Why?
Drug Eruptions
1
2015
28
0.030
 Why?
Mucositis
1
2015
20
0.030
 Why?
Education, Pharmacy
1
2017
121
0.030
 Why?
Cell Death
1
2017
383
0.030
 Why?
Analgesics
1
1997
228
0.030
 Why?
Pharmacy Residencies
1
2014
8
0.030
 Why?
Follow-Up Studies
2
2018
5389
0.030
 Why?
Immunohistochemistry
2
2009
1715
0.030
 Why?
Drug Discovery
1
2015
154
0.030
 Why?
Students, Pharmacy
1
2014
96
0.020
 Why?
Stroke Volume
1
2015
648
0.020
 Why?
Electrocardiography
1
2015
660
0.020
 Why?
Dioxoles
1
2011
9
0.020
 Why?
Tetrahydroisoquinolines
1
2011
8
0.020
 Why?
Biological Availability
1
2011
142
0.020
 Why?
Ambulatory Care
1
2016
597
0.020
 Why?
Mice
3
2020
18329
0.020
 Why?
Case-Control Studies
1
2018
3592
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2012
379
0.020
 Why?
Massage
1
2010
42
0.020
 Why?
Alopecia
1
2009
37
0.020
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2010
74
0.020
 Why?
Prognosis
1
2018
4278
0.020
 Why?
Quality of Health Care
1
2014
688
0.020
 Why?
Celecoxib
1
2008
41
0.020
 Why?
Bortezomib
1
2008
55
0.020
 Why?
Maximum Allowable Concentration
1
2008
16
0.020
 Why?
Floxuridine
1
2008
5
0.020
 Why?
Protein Kinase C beta
1
2008
21
0.020
 Why?
Guidelines as Topic
1
2010
267
0.020
 Why?
Dibenzocycloheptenes
1
2007
5
0.020
 Why?
Platelet Factor 4
1
2008
36
0.020
 Why?
Fibroblast Growth Factor 2
1
2008
92
0.020
 Why?
In Situ Nick-End Labeling
1
2007
121
0.020
 Why?
Matrix Metalloproteinase Inhibitors
1
2007
18
0.020
 Why?
Matrix Metalloproteinase 2
1
2007
55
0.020
 Why?
Antibiotics, Antineoplastic
1
2008
139
0.020
 Why?
Protein Prenylation
1
2006
19
0.020
 Why?
Carcinoid Tumor
1
2006
21
0.020
 Why?
Leiomyosarcoma
1
2006
28
0.020
 Why?
Protein Kinase C
1
2008
252
0.020
 Why?
Heparin
1
2008
243
0.020
 Why?
Thrombocytopenia
1
2008
205
0.020
 Why?
Cell Adhesion Molecules
1
2007
177
0.020
 Why?
Risk
1
2008
909
0.010
 Why?
Antimetabolites, Antineoplastic
1
2006
105
0.010
 Why?
Gastrointestinal Diseases
1
2008
216
0.010
 Why?
Inflammation
1
1997
2877
0.010
 Why?
Fibroblast Growth Factors
1
2006
188
0.010
 Why?
Antibody Formation
1
2006
294
0.010
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
109
0.010
 Why?
Monocytes
1
2008
538
0.010
 Why?
Combined Modality Therapy
1
2008
1264
0.010
 Why?
Disease Progression
1
2012
2840
0.010
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2006
257
0.010
 Why?
Carcinoma, Renal Cell
1
2006
234
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
2004
177
0.010
 Why?
Phosphorylation
1
2008
1732
0.010
 Why?
Gene Expression
1
2007
1487
0.010
 Why?
Gastrointestinal Tract
1
2004
208
0.010
 Why?
Endothelial Cells
1
2007
869
0.010
 Why?
Mutation
1
2012
4085
0.010
 Why?
Melanoma
1
2006
760
0.010
 Why?
Colorectal Neoplasms
1
2006
844
0.010
 Why?
Carrageenan
1
1997
8
0.010
 Why?
Magnetic Resonance Imaging
1
2010
3857
0.010
 Why?
Bradykinin
1
1997
48
0.010
 Why?
Substance P
1
1997
39
0.010
 Why?
Lyases
1
1997
16
0.010
 Why?
Edema
1
1997
124
0.010
 Why?
Substrate Specificity
1
1997
388
0.010
 Why?
Serotonin
1
1997
293
0.010
 Why?
Time Factors
1
2004
7155
0.010
 Why?
Kinetics
1
1997
1627
0.010
 Why?
Amino Acid Sequence
1
1997
2154
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2525
0.010
 Why?
Rats
1
1997
5592
0.000
 Why?
O'Bryant's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (316) concept(s)
_
Co-Authors Expand Description
See all (34) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)